Hostname: page-component-6bf8c574d5-l72pf Total loading time: 0 Render date: 2025-03-09T15:31:17.765Z Has data issue: false hasContentIssue false
  • English
  • Français

Case Studies in the Advancement of Parkinson's Disease

Published online by Cambridge University Press:  07 November 2014

Karen Frei ,
Daniel D. Truong  and
Erik Wolters
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Introduction
Information
CNS Spectrums , Volume 13 , Issue S18: Case Studies in the Advancement of Parkinson's Disease , December 2008 , pp. 3 - 6
Copyright
Copyright © Cambridge University Press 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Deuschl, G, Bain, P, DBrin, M. “Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee” Mov Disord. 1998;13(Suppl 3):2–23.CrossRefGoogle Scholar
2.Deuschl, G, Volkmann, J. Tremors: differential diagnosis, pathophysiology and theory. In Jankovik, J, Tolosa, E, eds. Parkinson's Disease and Movement Disorders. Philadelphia, PA: Lippincott, Williams and Wilkins; 2002:270–290.Google Scholar
3.Tan, EK, Lee, SS, Fook-Chong, S, Lum, SY. Evidence of increased odds of essential tremor in Parkinson's disease. Mov Disord. 2008;23(7):993–997.CrossRefGoogle ScholarPubMed
4.Rocca, WA, Bower, JH, Ahlskog, JE, et al. Increased risk of essential tremor in first-degree relatives of patients with Parkinson's disease. Mov Disord. 2007;22(11):1607–1614.CrossRefGoogle ScholarPubMed
5.Louis, ED, Honig, LS, Vonsattel, JP, Maraganore, DM, Borden, S, Moskowitz, CB. Essential tremor associated with focal nonnigral Lewy bodies: a clinicopathologic study. Arch Neurol. 2005;62(6):1004–1007.CrossRefGoogle ScholarPubMed
6.Yahr, MD, Orosz, D, Purohit, DP. Co-occurrence of essential tremor and Parkinson's disease: clinical study of a large kindred with autopsy findings. Parkinsonism Relat Disord. 2003;9(4):225–231.CrossRefGoogle ScholarPubMed
7.Chaudhuri, KR, Buxton-Thomas, M, Dhawan, V, Peng, R, Meilak, C, Brooks, DJ. Long duration asymmetrical postural tremor is likely to predict development of Parkinson's disease and not essential tremor: clinical follow up study of 13 cases. J Neurol Neurosurg Psychiatry. 2005;76(1):115–117.CrossRefGoogle Scholar
8.Riley, D. Secondary parkinsonism. In: Jankovic, JJ, Tolosa, E, eds. Parkinson's Disease and Movement Disorders, 4th ed.Philadelphia, PA: Lippincott, Williams and Wilkins: 2000;199–211.Google Scholar
9.Rascol, O, Olanow, CW. ADAGIO: A prospective, double-blind, delayed-start study to examine the disease-modifying effect of rasagiline in early Parkinson's disease (PD). Eur J Neurol. 2008;15(suppl 3):413.Google Scholar
10.Miyasaki, JM, Martin, W, Suchowersky, O, Weiner, WJ, Lang, AE. Practice parameter: initiation of treatment for Parkinson's disease: an evidence-based review: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2002;58(1):11–17.CrossRefGoogle Scholar
11.Suchowersky, O, Reich, S, Perlmutter, J, et al. Practice Parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2006;66(7):968–975.CrossRefGoogle Scholar
12.Postuma, RB, Gagnon, JF, Vendette, M, Charland, K, Montplaisir, J. Manifestations of Parkinson disease differ in association with REM sleep behavior disorder. Mov Disord. 2008;23(12):1665–1672.CrossRefGoogle ScholarPubMed
13.Wolters, ECh, van der Werf, YD, van den Heuvel, OA. Parkinson's disease-related disorders in the impulsive-compulsive spectrum. J Neurol. 2008;255(Suppl 5):48–56.CrossRefGoogle ScholarPubMed
14.Voon, V, Potenza, MN, Thomsen, T. Medication-related impulse control and repetitive behaviors in Parkinson's disease. Curr Opin Neurol. 2007;20(4):484–492.CrossRefGoogle ScholarPubMed
15.O'Sullivan, SS, Evans, AH, Lees, AJ. Punding in Parkinson's disease. Pract Neurol. 2007;7(6):397–399.CrossRefGoogle ScholarPubMed
16.Truong, DD, Bhidayasiri, R, Wolters, E. Management of non-motor symptoms in advanced Parkinson disease. J Neurol Sci. 2008;266(1–2):216–228.CrossRefGoogle ScholarPubMed
17.Kashihara, K, Imamura, T. Amantadine may reverse punding in Parkinson's disease--observation in a patient. Mov Disord. 2008; 23(1):129–130.CrossRefGoogle ScholarPubMed
18.Nyholm, D, Lewander, T, Johansson, A, Lewitt, PA, Lundqvist, C, Aquilonius, SM. “Enteral levodopa/ carbidopa infusion in advanced Parkinson disease: long-term exposure.” Clin Neuropharmacol. 2008;31(2):63–73.CrossRefGoogle ScholarPubMed
19.Witjas, T, Baunez, C, Henry, JM, et al. Addiction in Parkinson's disease: impact of subthalamic nucleus deep brain stimulation.” Mov Disord. 2005;20(8):1052–1055.CrossRefGoogle ScholarPubMed